Miscellaneous amused views on topics in the domains of neuropsychiatric epidemiology, defined broadly to encompass the entire envirome and genome, including infective agents; alcohol, tobacco, and other drugs; traumatic events; you name it. Comments welcome. Will be moderated by a volunteer among one of our MSU program's chief fellows or alum.
Monday, April 30, 2018
Sunday, April 22, 2018
Saturday, April 21, 2018
Friday, April 20, 2018
PIIYOW !!!
PIIYOW, PIIYOW !!!
Always, when you get feedback from advisors, do not recite what they say.
Read.
Digest what you can learn.
Write it, in your own words.
Put
It
In
Your
Own
Words
PIIYOW !!!
Saturday, April 14, 2018
Friday, April 13, 2018
Thursday, April 12, 2018
Wednesday, April 11, 2018
Psychedelics issue: ACNP journal, etc.
Belouin &Henningfield lead article, Feb 2018
Plus a “dark classic” in ACS Chem Neuroscience: Nichols, (March 2018): https://www.ncbi.nlm.nih.gov/pubmed/29476779
Plus two recent RCT with LSD:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420386/
Monday, April 9, 2018
Friday, April 6, 2018
Hard and soft drugs: reasons to avoid using these terms
Link to a critique, Janek et al., 2017
To cite this article: Peter Janik, Michaela Kosticova, Jan Pecenak Prof & Michal Turcek (2017) Categorization of psychoactive substances into “hard drugs” and “soft drugs”: a critical review of terminology used in current scientific literature, The American Journal of Drug and Alcohol Abuse, 43:6, 636-646, DOI: 10.1080/00952990.2017.1335736
Thursday, April 5, 2018
The X-Plan: ripe for a group-randomized trial.
DP5 material
Wednesday, April 4, 2018
New forms of nicotine products in the news.
Some epidemiological evidence in that article.
Anyone done a case-crossover study yet?
Tuesday, April 3, 2018
Monday, April 2, 2018
Opioids, cannabis, and pain: Use STROBE to analyze.
What is missing?
Subscribe to:
Posts (Atom)